| abstract |
PMLF 2850.3A -82- PATENT ABSTRACT A novel, nonphospholipid liposome formulation for sustained release and delivery of steroids. The formulation provides prolonged release of the drug, improved therapeutic ratio, lower toxicity, reduced systemic side effects and is stable for up to three months. The formulation is suitable for sustained delivery of steroid via inhalation, parenteral, intrathecal, intraarticular, topical, ophthalmic, and oral administration and is suitable for treatment of inflammatory, arthritic, rheumatoid, topic, pulmonary and interstitial lung diseases. |